Accurate classification of metastatic brain tumors using a novel microRNA-based test. Background: LTX-315 (Oncopore) is a chemically designed cationic nonapeptide derived from a natural host defensive ...
CHICAGO — Administering the bispecific antibody amivantamab (Rybrevant) subcutaneously rather than intravenously in combination with lazertinib (Leclaza) not only reduces administration times but also ...
ORLANDO, Fla.--(BUSINESS WIRE)-- Millennium: The Takeda Oncology Company today reported results from a randomized, international Phase III clinical trial comparing subcutaneous and intravenous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results